Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Today's most important initiations

Published 02/01/2023, 05:45 PM
Updated 02/01/2023, 06:17 PM
© Reuters.  Today's most important initiations

© Reuters. Today's most important initiations

Morgan Stanley initiated coverage on Rocket Pharmaceuticals (RCKT) with an Overweight rating and a price target of $45.00 as the leader in the gene therapy prepares to enter a pivotal study in Q2/23 with its RP-A501, the first and best-in-class treatment for Danon disease.

BofA Securities initiated coverage on New Fortress Energy (NFE) with a Buy rating and a price target of $67.00. Shares gained more than 4% today.

Mizuho Securities initiated coverage on General Mills (GIS) with a Neutral rating and a price target of $75.00.

Cantor Fitzgerald initiated coverage on Beam Therapeutics Inc (BEAM) with an Overweight rating and a price target of $62.00. Shares surged more than 5% today.

Raymond James initiated coverage on Everest Re Group (RE) with an Outperform rating and a price target of $385.00.

Raymond James initiated coverage on Accolade Inc. (ACCD) with an Outperform rating and a price target of $15.00.

By Davit Kirakosyan

Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.